Gold nanorod-assisted theranostic solution for nonvisible residual disease in bladder cancer.

MLA

Armanetti, Paolo, et al. “Gold Nanorod-Assisted Theranostic Solution for Nonvisible Residual Disease in Bladder Cancer.” Proceedings of the National Academy of Sciences of the United States of America, vol. 121, no. 37, Sept. 2024, p. e2411583121. EBSCOhost, https://doi.org/10.1073/pnas.2411583121.

APA

Armanetti, P., Locatelli, I., Venegoni, C., Alchera, E., Campanella, B., Pederzoli, F., Maturi, M., Locatelli, E., Tortorella, S., Curnis, F., Corti, A., Lucianò, R., Onor, M., Salonia, A., Montorsi, F., Moschini, M., Popov, V., Jose, J., Comes Franchini, M., … Alfano, M. (2024). Gold nanorod-assisted theranostic solution for nonvisible residual disease in bladder cancer. Proceedings of the National Academy of Sciences of the United States of America, 121(37), e2411583121. https://doi.org/10.1073/pnas.2411583121

Chicago

Armanetti, Paolo, Irene Locatelli, Chiara Venegoni, Elisa Alchera, Beatrice Campanella, Filippo Pederzoli, Mirko Maturi, et al. 2024. “Gold Nanorod-Assisted Theranostic Solution for Nonvisible Residual Disease in Bladder Cancer.” Proceedings of the National Academy of Sciences of the United States of America 121 (37): e2411583121. doi:10.1073/pnas.2411583121.